Application of the drug Melupirair production of Merck in the treatment of COVID-19 can provoke the appearance of new strains of coronavirus. This was stated by Virusologist William Haselt, who worked at Harvard University, reports Science magazine.
According to him, studies have shown that if the patients begin to improve the health of the health after the use of tablets and stop taking the drug, the organism of the virus particles begin to mutate and produce anti-drug.
Recall, November 4, the UK first in the world approved the use of melupira in the world in the treatment of patients with COVID-19.